Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27804103 | 0.89 | SMN1; SMN2 (0.49) | MAPTCYP3A4TSHRSMN1; SMN2ALDH1A1 | |
| SCHEMBL31365089 | 0.89 | ALDH1A1 (0.58) | MAPTCYP3A4SMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL8231247 | 0.89 | ALDH1A1 (0.58) | MAPTCYP3A4SMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL6433978 | 0.87 | RXFP1 (0.54) | MAPTSMN1; SMN2NPC1RAB9AKCNMA1 | |
| SCHEMBL30118370 | 0.86 | SMN1; SMN2 (0.45) | MAPTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL13833547 | 0.86 | SMN1; SMN2 (0.45) | MAPTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL2134731 | 0.86 | SMN1; SMN2 (0.45) | MAPTCYP3A4SMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL6674647 | 0.86 | L3MBTL1 (0.54) | MAPTTSHRSMN1; SMN2ALDH1A1KCNMA1 | |
| SCHEMBL1130860 | 0.85 | SMN1; SMN2 (0.66) | MAPTCYP3A4SMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL27782492 | 0.84 | SMN1; SMN2 (0.47) | MAPTSMN1; SMN2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4741395-A1 | NOVEL COMPOUND SENSITIVE TO NITROGEN MONOXIDE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Omniamed Co. Ltd (KR) | 2026-05-13 | — | — | EP | disclosed |
| WO-2025009922-A1 | NOVEL COMPOUND SENSITIVE TO NITROGEN MONOXIDE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 옴니아메드 | 2025-01-09 | — | — | WO | disclosed |